Indications
- Pulmonary Hypertension (see Pulmonary Hypertension, [[Pulmonary Hypertension]])
- Idiopathic Pulmonary Arterial Hypertension (IPAH) (see Idiopathic Pulmonary Arterial Hypertension, [[]Idiopathic Pulmonary Arterial Hypertension])
Pharmacology
- cGMP-Specific Phosphodiesterase Type 5 (PDE5) Inhibitor
Administration
- PO:
Adverse Effects
Cardiovascular Adverse Effects
- Hypotension (see Hypotension, [[Hypotension]])
Other Adverse Effects
- xxx
References
- xxx